Drug intelligence / Profile preview

Liangxue Jiedu Runzhi

Development stage
Preclinical
Lead developer
Beijing Hospital of Traditional Chinese Medicine
Administration
Topical
01

Overview

Liangxue Jiedu Runzhi (LJR) is a topical traditional Chinese medicine (TCM) ointment investigated for the treatment of mild-to-moderate psoriasis vulgaris with blood-heat syndrome. It is a polyherbal formulation containing Chinese angelica (Radix Angelicae Sinensis), Arnebia root (Radix Arnebiae), Rhubarb root and rhizome (Radix et Rhizoma Rhei), Natural indigo (Indigo Naturalis), Belvedere fruit (Fructus Kochiae), Light yellow sophora root (Radix Sophorae Flavescentis), and Glabrous greenbrier rhizome (Rhizoma Smilacis Glabrae) in a base of sesame oil, vaseline, and beeswax. The mechanism of action is not fully elucidated but is believed to stem from the synergistic effects of its components, which include inhibiting keratinocyte proliferation, reducing inflammation by modulating cytokines such as TNF-α and IL-8, and restoring the skin's barrier function. In a double-blind, randomized controlled trial, LJR ointment demonstrated superior efficacy over a placebo in improving Psoriasis Area and Severity Index (PASI) scores.

Other names
Liangxue Jiedu Runzhi ointment
02

Targets

CCR6 (C-C motif chemokine receptor 6)TNFA (Tumor necrosis factor alpha (soluble))CDK (CDK family)STAT3 (Signal Transducer and Activator of Transcription 3)CCL20 (C-C motif chemokine ligand 20)IL-17A (Interleukin-17A)IL8 (C-X-C Motif Chemokine Ligand 8)

Beyond the preview

Go deeper on Liangxue Jiedu Runzhi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liangxue Jiedu Runzhi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call